Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 45

Page
per page
  1. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  2. NSC 3852
    A4496 NSC 3852
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
  3. Floxuridine
    A2402 Floxuridine
    Target: Synthases/Synthetases
    Summary: Antineoplastic antimetabolite
      ≥12.31 mg/mL
  4. Carboplatin
    A2171 Carboplatin
    Summary: Antitumor agent that forms platinum-DNA adducts.
      insoluble in ETOH; ≥9.28 mg/mL
  5. Camptothecin
    A2877 Camptothecin
     1 Citation
    Target: Topoisomerases
    Summary: Topoisomerase I inhibitor,prototypic
      insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
  6. Gemcitabine HCl
    A1402 Gemcitabine HCl
    Summary: Inhibits DNA synthesis,deoxycytidine analog
      ≥10.1 mg/mL
  7. Dacarbazine
    A2197 Dacarbazine
    Target: DNA Alkylating
    Summary: Antineoplastic( malignant melanoma and sarcomas)
      insoluble in EtOH; ≥0.54 mg/mL
  8. Ifosfamide
    A2097 Ifosfamide
    Target: DNA Alkylating
    Summary: Cytostatic agent
      ≥13.05 mg/mL
  9. Epirubicin HCl
    A2451 Epirubicin HCl
    Target: Topoisomerases
    Summary: Antibiotic antitumor agent
      ≥29.00 mg/mL
  10. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL

Items 1-10 of 45

Page
per page